Chronic lead intoxication affects glial and neural systems and induces hypoactivity in adult rat

Acta Histochemica

Volumn 113, Issue 6, 2011, Pages 601-607

  Sansar, Wafa ^a   Ahboucha, Samir ^a   Gamrani, Halima ^a  

^a FACULTÉ DES SCIENCES SEMLALIA   (Morocco)

Author keywords

Adult rat; Astrocyte; Dopaminergic neurons; Immunohistochemistry; Lead; Locomotor activity; Western blot

Indexed keywords

DRINKING WATER; GLIAL FIBRILLARY ACIDIC PROTEIN; LEAD ACETATE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD VESSEL; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; FRONTAL CORTEX; GLIA CELL; HYPOACTIVITY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEAD POISONING; LOCOMOTION; MACROGLIA; MALE; MOTOR DYSFUNCTION; NONHUMAN; OPEN FIELD TEST; RAT; SUBSTANTIA NIGRA; WESTERN BLOTTING;

ANIMALS; CHRONIC DISEASE; IMMUNOHISTOCHEMISTRY; LEAD POISONING; MALE; MOTOR ACTIVITY; NEUROGLIA; NEURONS; ORGANOMETALLIC COMPOUNDS; RATS; RATS, WISTAR; TOXICITY TESTS;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 79957881204     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2010.06.005     Document Type: Article

References (53)

1. Ahboucha S., Didier-Bazes M., Meiniel A., Fèvre-Montange M., Gamrani H. Secretory activity and serotonin innervation of lizard's subcommissural organ. Neuroreport 2000, 11:2611-2615.
2. Alfano D.P., Petit T.L., LeBoutillier J.C. Development and plasticity of the hippocampal cholinergic system in normal and early lead exposed rats. Brain Res 1983, 312:117-124.
3. Araque A., Parpura V., Sanzgiri R.P., Haydon P.G. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 1999, 22:208-215.
4. Bielarczyk H., Tomsig J.L., Suszkiw J.B. Perinatal low-level lead exposure and the septo-hippocampal cholinergic system: selective reduction of muscarinic receptors and cholineacetyltransferase in the rat septum. Brain Res 1994, 643:211-217.
5. Bouyatas M.M., Gamrani H. Immunohistochemical evaluation of the effect of lead exposure on subcommissural organ innervation and secretion in Shaw's Jird (Meriones shawi). Acta Histochem 2007, 109:421-427.
6. Bradbury M.W., Deane R. Permeability of the blood-brain barrier to lead. Neurotoxicology 1993, 14:131-136.
7. Brown A.M., Baltan Tekkok S., Ransom B.R. Energy transfer from astrocytes to axons: the role of CNS glycogen. Neurochem Int 2004, 45:529-536.
8. Canfield R.L., Henderson C.R., Cory-Slechta D.A., Cox C., Jusko T.A., Lanphear B.P. Intellectual impairment in children with blood lead concentrations below 10micrograms per decilitre. New Engl J Med 2003, 348:1517-1526.
9. Cory-Slechta D.A. Relationships between lead-induced learning impairments and changes in dopaminergic, cholinergic and glutamatergic neurotransmitter system functions. Annu Rev Pharmacol Toxicol 1995, 35:391-415.
10. Devi C.B., Reddy G.H., Prasanthi R.P.J., Chetty C.S., Reddy G.R. Developmental lead exposure alters mitochondrial monoamine oxidase and synaptosomal catecholamine levels in rat brain. Int J Dev Neurosci 2005, 23:375-381.
11. Djebli N., Slimani M., Aoues A. Effect of lead exposure on dopaminergic transmission in the rat brain. Toxicology 2005, 207:363-368.
12. Elmariah S.B., Hughes E.G., Oh E.J., Balice-Gordon R.J. Neurotrophin signaling among neurons and glia during formation of tripartite synapses. Neuron Glia Biol 2005, 1:1-11.
13. Engele J., Schubert D., Bohn M.C. Conditioned media derived from glial cell lines promote survival and differentiation of dopaminergic neurons in vitro: role of mesencephalic glia. J Neurosci Res 1991, 30:359-371.
14. Erazi H., Sansar W., Ahboucha S., Gamrani H. Aluminum affects glial system and behavior of rats. C R Biol 2010, 333:23-27.
15. Fellin T., Carmignoto G. Neuron to astrocyte signaling in the brain represents a distinct multifunctional unit. J Physiol 2004, 559:3-15.
16. Fortune T., Lurie D. Chronic low-level lead exposure affects the monoaminergic system in the mouse superior olivary complex. J Comp Neurol 2009, 513:542-558.
17. Fox D.A., Kala S.V., Hamilton W.R., Johnson J.E., O'Callaghan J.P. Low-level human equivalent gestational lead exposure produces supernormal scotopic electroretinograms, increased retinal neurogenesis, and decreased retinal dopamine utilization in rats. Environ Health Perspect 2008, 116:618-625.
18. Gebhart A.M., Goldstein G.W. Use of in vitro system to study the effects of lead on astrocyte-endothelial cell interactions: a model for studying toxic injury to the blood-brain barrier. Toxicol Appl Pharmacol 1988, 94:191-206.
19. Guilarte T.R. Glutamatergic system and developmental lead neurotoxicity. Neurotoxicology 1997, 18:665-672.
20. Hansson E., Ronnback L. Glial neuronal signaling in the central nervous system. FASEB J 2003, 17:341-348.
21. Harry G.J., Schmitt T.J., Gong Z., Brown H., Zawia N., Evans H.L. Lead induced alterations of glial acidic protein (GFAP) in the developing rat brain. Toxicol Appl Pharmacol 1996, 139:84-93.
22. Holtzman D., De Vries C., Nguyen H., Jameson N., Olson J., Carrithers M., et al. Development of resistance to lead encephalopathy during maturation in the rat pup. J Neuropathol Exp Neurol 1982, 41:652-663.
23. Hou J.G., Cohen G., Mytilineou C. Basic fibroblast growth factor stimulation of glial cells protects dopamine neurons from 6-hydroxydopamine toxicity: involvement of the glutathione system. J Neurochem 1997, 69:76-83.
24. Ishihara K., Alkondon M., Montes J.G., Albuquerque E.X. Nicotinic responses in acutely dissociated rat hippocampal neurons and the selective blockade of fast-desensitizing nicotinic currents by lead. J Pharmacol Exp Ther 1995, 273:1471-1482.
25. Kaushik P., Gorin F., Vali S. Dynamics of tyrosine hydroxylase mediated regulation of dopamine synthesis. J Comput Neurosci 2007, 22:147-160.
26. Kohler K., Lilienthal H., Guenther E., Winneke G., Zrenner E. Persistent decrease of the dopamine-synthesizing enzyme tyrosine hydroxylase in the rhesus monkey retina after chronic lead exposure. Neurotoxicology 1997, 18:623-632.
27. Krass B., Winneke G., Krämer U. Neurobehavioral and systemic effects in lead-exposed rats after an exposure-free interval of four months duration. Zentralbl Bakteriol B 1980, 170:353-367.
28. Lasley S.M., Greenland R.D., Minnema D.J., Michaelson I.A. Influence of chronic inorganic lead exposure on regional dopamine and 5-hydroxytryptamine turnover in rat brain. Neurochem Res 1984, 9:1675-1688.
29. Lasley S.M., Green M.C., Gilbert M.E. Rat hippocampal NMDA receptor binding as a function of chronic lead exposure level. Neurotoxicol Teratol 2001, 23:185-189.
30. Leret M.L., Garcia-Uceda F., Antonio M.T. Effects of maternal lead administration on monoaminergic, GABAergic and glutamatergic systems. Brain Res Bull 2002, 58:469-473.
31. Lindahl L.S., Bird L., Legare M.E., mikeska G., Bratton G.R., Tiffany-Castiglioni E. Differential ability of astroglia and neuronal cells to accumulate lead: dependence on cell type and on degree of differentiation. Toxicol Sci 1999, 50:236-243.
32. Mena M.A., Casarejos M.J., Carazo A., Paino C.L., Garcia de Yebenes J. Glia conditioned medium protects fetal rat midbrain neurons in culture from l-DOPA toxicity. Neuroreport 1996, 7:441-445.
33. Ohta K., Kuno S., Inoue S., Ikeda E., Fujinami A., Ohta M. The effect of dopamine agonists: the expression of GDNF, NGF, and BDNF in cultured mouse astrocytes. J Neurol Sci 2010, 291:12-16.
34. O'Malley E.K., Sieber B.A., Morrison R.S., Black I.B., Dreyfus C.F. Nigral type I astrocytes release a soluble factor that increases dopaminergic neuron survival through mechanisms distinct basic fibroblast growth factor. Brain Res 1994, 647:83-90.
35. Pan Y., Berman Y., Haberny S., Meller E., Carr K.D. Synthesis, protein levels, activity, and phosphorylation state of tyrosine hydroxylase in mesoaccumbens and nigrostriatal dopamine pathways of chronically food-restricted rats. Brain Res 2006, 1122:135-142.
36. Pokora M.J., Richfield E.K., Cory-Slechta D.A. Preferential vulnerability of nucleus accumbens dopamine binding sites to low-level lead exposure: time course of effects and interactions with chronic dopamine agonist treatments. J Neurochem 1996, 67:1540-1550.
37. Selvín-Testa A., Capani F., Loidl C.F., Lopez E.M., Pecci Saavedra J. Prenatal and postnatal lead exposure induces 70kDA heat shock protein in young rat brain prior to changes in astrocyte cytoskeleton. NeuroToxicology 1997, 18:805-818.
38. Stoltenburg-Didinger G., Pünder I., Peters B., Marcinkowski M., Herbst H., Winneke G., et al. Glial fibrillary acidic protein and RNA expression in adult rat hippocampus following low-level lead exposure during development. Histochem Cell Biol 1996, 105:431-442.
39. Struzyñska L., Bubko I., Walski M., Rafałowska U. Astroglial reaction during the early phase of acute lead toxicity in the adult rat brain. Toxicology 2001, 165:121-131.
40. Struzyñska L., Chalimoniuk M., Sulkowski G. Changes in expression of neuronal and glial glutamate transporters in lead-exposed adult rat brain. Neurochem Int 2005, 47:326-333.
41. Struzyñska L., Dabrowska-Bouta B., Koza K., Sulkowski G. Inflammation-like glial response in lead-exposed immature rat brain. Toxicol Sci 2007, 95:156-162.
42. Szczerbak G., Nowak P., Kostrzewa R.M., Brus R. Maternal lead exposure produces long-term enhancement of dopaminergic reactivity in rat offspring. Neurochem Res 2007, 32:1791-1798.
43. Tavakoli-Nezhad M., Barron A.J., Pitts D.K. Postnatal inorganic lead exposure decreases the number of spontaneously active midbrain dopamine neurons in the rat. Neurotoxicology 2001, 22:259-269.
44. Tiffany-Castiglioni E. Cell culture models for lead toxicity in neuronal and glial cells. Neurotoxicology 1993, 14:513-536.
45. Tiffany-Castiglioni E., Guerri C., Aschner M., Matsushima G.K., O'Callaghan J.P., Streit W.J. Roles of glia in developmental neurotoxicity: session VI summary and research needs. Neurotoxicology 2001, 22:567-573.
46. Toscano C.D., Guilarte T.R. Lead neurotoxicity: from exposure to molecular effects. Brain Res Brain 2005, 49:529-554.
47. Tsacopoulos M., Magistretti P.J. Metabolic coupling between glia and neurons. J Neurosci 1996, 16:877-885.
48. Van den Heuvel D.M., Pasterkamp R.J. Getting connected in the dopamine system. Prog Neurobiol 2008, 85:75-93.
49. Vilaplana J., Lavialle M. A method to quantify glial fibrillary acidic protein immunoreactivity on the suprachiasmatic nucleus. J Neurosci Methods 1999, 88:181-187.
50. White L.D., Cory-Slechta D.A., Gilbert M.E., Tiffany-Castiglioni E., Zawia N.H., Virgolini M., et al. New and evolving concepts in the neurotoxicology of lead. Toxicol Appl Pharmacol 2007, 225:1-27.
51. Wilson M.A., Johnston M.V., Goldstein G.W., Blue M.E. Neonatal lead exposure impairs development of rodent barrel field cortex. Proc Natl Acad Sci U S A 2000, 97:5540-5545.
52. Yun S.W., Gärtner U., Arendt T., Hoyer S. Increase in vulnerability of middle-aged rat brain to lead by cerebral energy depletion. Brain Res Bull 2000, 52:371-378.
53. Zawia N.H., Harry G.J. Developmental exposure to lead interferes with glial and neuronal differential gene expression in the rat cerebellum. Toxicol Appl Pharmacol 1996, 138:43-47.